ArticleFrontiers in cellular and infection microbiology2026
CT-based radiomics models for predicting the prognosis of children with mycoplasma pneumonia.
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In recent years, the incidence of mycoplasma pneumonia (MP) in children has gradually increased; however, to date, few studies have assessed its prognosis in children. Hence, the present study aimed to develop a prognostic model for children with MP by using clinical data and radiomics features extracted from chest computed tomography (CT) images. Methods: A total of 356 children with MP from two hospitals were enrolled in the study. These patients were randomly assigned to a training set (n = 206), a test set (n = 52), and a validation set (n = 98). Clinical data, including patients' history and demographics, laboratory test results, and CT imaging features, were collected. Radiomics features of the infected lesions were extracted from chest CT images. Univariate analysis was performed to determine the most predictive features with significant differences (P < 0.05) among all imaging and clinical data. Least absolute shrinkage and selection operator was used to select radiomics features and estimate the prediction performance of the clinical factors model and the radiomics model for prognosis. Results: In the training set, the clinical factors (creatine kinase-MB, lactate dehydrogenase, C-reactive protein, bilateral lobe pneumonia, number of lobes, and lesion volume) showed a significant prognostic value (all P < 0.05) and were selected to construct the clinical model. The area under the curve (AUC) values of the clinical model for the training, validation, and test sets were 0.767, 0.731, and 0.685, respectively. Twenty one radiomics features were selected. The AUC values of the radiomics model for the training, validation, and test sets were 0.829, 0.775, and 0.701, respectively. Decision curve analysis showed that the radiomics model has potential clinical application value for predicting the prognosis of children with MP. The clinical and radiomics model showed the best prediction performance, with AUC values of 0.842, 0.825, and 0.748 for the training, validation, and test sets, respectively. Conclusion: The radiomics model based on CT imaging features showed potential as a quantitative tool to predict the prognosis of children with MP. The addition of radiomics features to the clinical factors improved the diagnostic efficiency of the clinical and radiomics model. Thus, the combination of clinical data and radiomic features effectively predicted the prognostic outcome of children with MP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.